4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-041730
Chief Operating Officer sold 3,125 shares at an average $10.22 ($31,943)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2022-07-07 | Sale | −825 | $9.53 | $7,862 | 122,068 | D |
| ADAMS R MARK Chief Operating Officer | 2022-07-08 | Sale | −2,300 | $10.47 | $24,081 | 119,768 | D |
| Open-market sales · 3,125 sh · avg $10.22 · $31,943 | |||||||
Loading xslF345X03/doc4.xml…